Key result
Novel SCN5A p.P1506S mutation linked to ~34-msec PR interval prolongation.
Why the study?
Does the novel SCN5A p.P1506S genetic variant (alongside KCNH2 p.R25W) cause Nav1.5 loss of function and explain the Brugada syndrome phenotype in a large Iranian family?
Observational (n=15)
Does the novel SCN5A p.P1506S genetic variant (alongside KCNH2 p.R25W) cause Nav1.5 loss of function and explain the Brugada syndrome phenotype in a large Iranian family?
Identifies a novel loss-of-function SCN5A p.P1506S variant alongside KCNH2 p.R25W in a single Brugada syndrome family, demonstrating that multiple independent genetic variants can coexist and contribute to familial cardiac channelopathies.
Answers are grounded in this paper and cite their sources.
Supports functional studies of SCN5A variants in Brugada families; leaves open digenic contributions to phenotype severity.
The Brugada syndrome (BrS) is an inherited arrhythmia characterized by ST-segment elevation in V1-V3 leads and negative T wave on standard ECG. BrS patients are at risk of sudden cardiac death (SCD) due to ventricular tachyarrhythmia. At least 17 genes have been proposed to be linked to BrS, although recent findings suggested a polygenic background. Mutations in SCN5A, the gene coding for the cardiac sodium channel Nav1.5, have been found in 15-30% of index cases. Here, we present the results of clinical, genetic, and expression studies of a large Iranian family with BrS carrying a novel genetic variant (p.P1506S) in SCN5A. By performing whole-cell patch-clamp experiments using HEK293 cells expressing wild-type (WT) or p.P1506S Nav1.5 channels, hyperpolarizing shift of the availability curve, depolarizing shift of the activation curve, and hastening of the fast inactivation process were observed. These mutant-induced alterations lead to a loss of function of Nav1.5 and thus suggest that the p.P1506S variant is pathogenic. In addition, cascade familial screening found a family member with BrS who did not carry the p.P1506S mutation. Additional next generation sequencing analyses revealed the p.R25W mutation in KCNH2 gene in SCN5A-negative BrS patients. These findings illustrate the complex genetic background of BrS found in this family and the possible pathogenic role of a new SCN5A genetic variant.
No takes yet. Share an insight, caveat, or question.
Saber et al. (2015) conducted an observational in Brugada syndrome (n=15). SCN5A p.P1506S mutation vs. Wild-type Nav1.5 / SCN5A-negative noncarriers was evaluated on PR interval duration (msec) in family members (p=0.01).
Synapse has enriched 10 related papers. Consider them for comparative context: